Sustained efficacy and reduced hypoglycemia during one year of treatment with vildagliptin added to insulin in patients with type 2 diabetes mellitus

被引:65
作者
Fonseca, V. [1 ]
Baron, M. [2 ]
Shao, Q. [2 ]
Dejager, S. [2 ]
机构
[1] Tulane Univ, Hlth Sci Ctr, Dept Endocrinol, New Orleans, LA 70112 USA
[2] Novartis Pharmaceut Corp, E Hanover, NJ USA
关键词
D O I
10.1055/s-2008-1058090
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:427 / 430
页数:4
相关论文
共 13 条
[11]   COUNTERREGULATORY HORMONE RESPONSES TO HYPOGLYCEMIA IN THE ELDERLY PATIENT WITH DIABETES [J].
MENEILLY, GS ;
CHEUNG, E ;
TUOKKO, H .
DIABETES, 1994, 43 (03) :403-410
[12]   Efficacy and tolerability of vildagliptin monotherapy in drug-naive patients with type 2 diabetes [J].
Pi-Sunyer, F. Xavier ;
Schweizer, Anja ;
Mills, David ;
Dejager, Sylvie .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 76 (01) :132-138
[13]   Comparison of vildagliptin and rosiglitazone monotherapy in patients with type 2 diabetes - A 24-week, double-blind, randomized trial [J].
Rosenstock, Julio ;
Mills, David ;
Baron, Michelle A. ;
Schweizer, Anja ;
Dejager, Sylvie .
DIABETES CARE, 2007, 30 (02) :217-223